Integrum AB (publ) (FRA:6Y1)

Market Cap	19.52M -52.7%
Revenue (ttm)	8.85M -1.4%
Net Income	-4.27M
EPS	-0.18
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.6680
Previous Close	0.6450
Day's Range	0.6680 - 0.6680
52-Week Range	0.5880 - 3.9050
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 4, 2026

About Integrum AB

Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. It also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputa...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1990
• Employees: 34
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 6Y1

Financial Performance

In fiscal year 2026, Integrum AB's revenue was 96.14 million, a decrease of -1.42% compared to the previous year's 97.52 million. Losses were -46.34 million, 50.4% more than in 2025.

Financial numbers in SEK

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 27, 2026

Data Sources Report a data error